CN Patent

CN115989022A — 口服用药物组合物及其制备方法

Assigned to Arthur Treatment Co ltd · Expires 2023-04-18 · 3y expired

What this patent protects

本发明提供一种药物组合物，其用于口服给药具有pH依赖性的溶解曲线的药物活性成分，且不受消化道内pH的影响，可实现优异的吸收效率。该口服用药物组合物包含具有pH依赖性的溶解曲线的药物活性成分、无机酸或有机酸以及亲水性聚合物。

USPTO Abstract

本发明提供一种药物组合物，其用于口服给药具有pH依赖性的溶解曲线的药物活性成分，且不受消化道内pH的影响，可实现优异的吸收效率。该口服用药物组合物包含具有pH依赖性的溶解曲线的药物活性成分、无机酸或有机酸以及亲水性聚合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN115989022A
Jurisdiction
CN
Classification
—
Expires
2023-04-18
Drug substance claim
No
Drug product claim
No
Assignee
Arthur Treatment Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.